McConalogue K, Grady E F, Minnis J, Balestra B, Tonini M, Brecha N C, Bunnett N W, Sternini C
Department of Surgery, University of California, San Francisco 94143-0660, USA.
Neuroscience. 1999 Mar;90(3):1051-9. doi: 10.1016/s0306-4522(98)00514-4.
The multiple effects of opiate alkaloids, important therapeutic drugs used for pain control, are mediated by the neuronal miro-opioid receptor. Among the side effects of these drugs is a profound impairment of gastrointestinal transit. Endomorphins are opioid peptides recently isolated from the nervous system, which have high affinity and selectivity for micro-opioid receptors. Since the miro-opioid receptor undergoes ligand-induced receptor endocytosis in an agonist-dependent manner, we compared the ability of endomorphin-1, endomorphin-2 and the micro-opioid receptor peptide agonist, [D-Ala2,MePhe4,Gly-ol5]-enkephalin (DAMGO), to induce receptor endocytosis in cells transfected with epitope-tagged micro-opioid receptor complementary DNA, and in myenteric neurons of the guinea-pig ileum, which naturally express this receptor. Immunohistochemistry with antibodies to the FLAG epitope or to the native receptor showed that the micro-opioid receptor was mainly located at the plasma membrane of unstimulated cells. Endomorphins and DAMGO induced micro-opioid receptor endocytosis into early endosomes, a process that was inhibited by naloxone. Quantification of surface receptors by flow cytometry indicated that endomorphins' and DAMGO stimulated endocytosis with similar time-course and potency. They inhibited with similar potency electrically induced cholinergic contractions in the longitudinal muscle-myenteric plexus preparation through an action antagonized by naloxone. The apparent affinity estimate of naloxone (pA2 approximately 8.4) is consistent with antagonism at the micro-opioid receptor in myenteric neurons. These results indicate that endomorphins directly activate the micro-opioid receptor in neurons, thus supporting the hypothesis that they are ligands mediating opioid actions in the nervous system. Endomorphin-induced micro-opioid receptor activation can be visualized by receptor endocytosis.
阿片生物碱是用于控制疼痛的重要治疗药物,其多种作用是由神经元微阿片受体介导的。这些药物的副作用之一是严重损害胃肠蠕动。内吗啡肽是最近从神经系统分离出的阿片肽,对微阿片受体具有高亲和力和选择性。由于微阿片受体会以激动剂依赖的方式发生配体诱导的受体内吞作用,我们比较了内吗啡肽-1、内吗啡肽-2以及微阿片受体肽激动剂[D-丙氨酸2,甲硫苯丙氨酸4,甘醇5]-脑啡肽(DAMGO)在转染了表位标记的微阿片受体互补DNA的细胞以及天然表达该受体的豚鼠回肠肌间神经元中诱导受体内吞的能力。用针对FLAG表位或天然受体的抗体进行免疫组织化学显示,微阿片受体主要位于未受刺激细胞的质膜上。内吗啡肽和DAMGO诱导微阿片受体内吞进入早期内体,这一过程被纳洛酮抑制。通过流式细胞术对表面受体进行定量分析表明,内吗啡肽和DAMGO刺激内吞作用的时间进程和效力相似。它们通过纳洛酮拮抗的作用,以相似的效力抑制纵向肌-肌间神经丛标本中的电诱导胆碱能收缩。纳洛酮的表观亲和力估计值(pA2约为8.4)与肌间神经元中微阿片受体的拮抗作用一致。这些结果表明,内吗啡肽直接激活神经元中的微阿片受体,从而支持了它们是介导神经系统中阿片样作用的配体这一假说。内吗啡肽诱导的微阿片受体激活可以通过受体内吞作用观察到。